Zhisong Dai
Biographic Data
| ID | 10000063 |
|---|---|
| NAME | Zhisong Dai |
| GIVEN NAMES | Zhisong |
| FAMILY NAME | Dai |
| SIGNATURE | DAI Z |
| AFFILIATIONS | Taiwan Centers for Disease Control |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Analysis of the utilization and effectiveness of tuberculosis digital adherence technology in southeastern China
Background In response to the World Health Organization’s advocacy for patient-centered care, Fujian Province, China, initiated the promotion of Digital Adherence Technology (DAT) in 2024 as an optional strategy to enhance treatment adherence—a critical determinant of patient outcomes. This study aimed to evaluate the real-world implementation and effectiveness of this program. Methods We conducted a multi-site study in four prefecture-level citi…
Fluoroquinolone resistance and mutation profiles in Mycobacterium tuberculosis through whole genome sequencing in Fujian province, China
Objective This study aimed to characterize fluoroquinolone (FQs) resistance and associated gene mutations in Mycobacterium tuberculosis (MTB) isolates from Fujian Province, with the goal of providing evidence to support precise prevention and control strategies for drug-resistant tuberculosis (TB). Methods A retrospective analysis was performed on 150 clinical MTB isolates collected from drug resistance surveillance sites. Phenotypic drug suscept…
Rifampicin-resistant tuberculosis in Fujian Province, Southeast China
Backgrounds Rifampicin-resistant tuberculosis (RR-TB) remains a major challenge to global TB control efforts. In Fujian Province, Southeast China, where RR-TB prevalence has been notably high, understanding epidemiological trends and treatment outcomes is crucial for optimizing interventions. This study aimed to analyze RR-TB characteristics, resistance patterns, and treatment outcomes to inform evidence-based control strategies. Methods An obser…
No prominent works on this page.
Rifampicin-resistant tuberculosis in Fujian Province, Southeast China
Backgrounds Rifampicin-resistant tuberculosis (RR-TB) remains a major challenge to global TB control efforts. In Fujian Province, Southeast China, where RR-TB prevalence has been notably high, understanding epidemiological trends and treatment outcomes is crucial for optimizing interventions. This study aimed to analyze RR-TB characteristics, resistance patterns, and treatment outcomes to inform evidence-based control strategies. Methods An obser…
Analysis of the utilization and effectiveness of tuberculosis digital adherence technology in southeastern China
Background In response to the World Health Organization’s advocacy for patient-centered care, Fujian Province, China, initiated the promotion of Digital Adherence Technology (DAT) in 2024 as an optional strategy to enhance treatment adherence—a critical determinant of patient outcomes. This study aimed to evaluate the real-world implementation and effectiveness of this program. Methods We conducted a multi-site study in four prefecture-level citi…
Fluoroquinolone resistance and mutation profiles in Mycobacterium tuberculosis through whole genome sequencing in Fujian province, China
Objective This study aimed to characterize fluoroquinolone (FQs) resistance and associated gene mutations in Mycobacterium tuberculosis (MTB) isolates from Fujian Province, with the goal of providing evidence to support precise prevention and control strategies for drug-resistant tuberculosis (TB). Methods A retrospective analysis was performed on 150 clinical MTB isolates collected from drug resistance surveillance sites. Phenotypic drug suscept…
Tuberculosis (3 works) · Tuberculosis Research and Epidemiology (3 works) · Diagnosis and treatment of tuberculosis (2 works) · Drug resistance (2 works) · Mycobacterium tuberculosis (2 works) · Biology (1 work) · China (1 work) · Confidence interval (1 work) · Diverse Scientific Research Studies (1 work) · Epidemiology (1 work)